Skip to content
Michael Warren /

Pause on China Tariffs Prompts Optimism, Uncertainty

The markets have rewarded the Trump administration’s walkbacks, but the president is still a true believer in trade protectionism.
President Trump Announces Plan To Reduce The Cost Of Prescription Drugs
President Donald Trump speaks during a press conference in the Roosevelt Room of the White House on May 12, 2025, in Washington, D.C. During the event, President Trump signed an executive order aimed at reducing the cost of prescription drugs and pharmaceuticals. (Photo by Andrew Harnik/Getty Images)

We have reached the beginning of the end of Donald Trump’s tariff experiment.

That, at least, is what professional Washington appears to be forecasting—or is it wishcasting? On Zoom calls and in leadership meetings up and down K Street Monday morning, lobbyists expressed cautious hope that the president may be done with these pesky trade actions soon, perhaps long before the end of the year.

Want to see more of The Dispatch in Google search?

Add Us as a Preferred Source

Michael Warren is politics editor at The Dispatch and is based in Washington, D.C. A former on-air reporter at CNN and a senior writer at The Weekly Standard, he has spent more than 15 years covering lawmakers on Capitol Hill, the White House and the executive branch, the conservative movement, and political campaigns. When Mike is not reporting, writing, editing, and podcasting, he is probably spending time with his wife and three sons.

More on Trump’s Trade War

Loading